Effect of the glucagon‐like peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
Work
Year: 2023
Type: article
Abstract: To investigate the hypothesis that weight loss with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide alone would lead to a greater reduction in the proportion of fat to lean tissue m... more
Source: Diabetes Obesity and Metabolism
Institutions Vanderbilt University Medical Center, VA Tennessee Valley Healthcare System, Yale University
Cites: 60
Cited by: 29
Related to: 10
FWCI: 10.12
Citation percentile (by year/subfield): 100
Topic: Diet and metabolism studies
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Zero hunger
Open Access status: green
Funders American Heart Association, Novo Nordisk Foundation Center for Basic Metabolic Research, National Center for Advancing Translational Sciences
Grant IDS 17SFRN33520017, , CTSA award #UL1TR002243